GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
about
Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels.Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studyPotentiating effects of GHRH analogs on the response to chemotherapy.New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's diseaseNew therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones.Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108.Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesSuppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer.Expression of hypothalamic neurohormones and their receptors in the human eye
P2860
Q34101055-D74BE3C4-F003-4644-8040-A78B1A93803DQ34781112-1E43D0D2-3F05-46B9-BB65-91EDC007CFEDQ35565027-047284F9-11EA-43FB-A549-CCAA39A97B99Q35833122-EB722355-EC07-4BEA-96B8-B0D56CA76CA8Q36189529-3F466C35-C6A9-4B7B-8492-EDCF0184676BQ36576387-5F79C03A-FFEE-4B93-A91B-557D52EE3173Q36748502-C80162F6-FD93-472B-84A3-363D186AB706Q37093547-5952C453-F626-430C-85B0-E8310EB9F32FQ38216009-D6F6057F-2963-4A73-B6A0-1FA3D352D603Q39201247-2A4AB127-CC83-4BB8-8D0C-95EF25C09F5FQ42330184-A1336DF4-0074-4D09-8712-63B4237CD7EBQ42366509-8B56F1DE-3043-4CA0-AF53-6E2F8197C496
P2860
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
GHRH antagonist when combined ...... ibition of human colon cancer.
@ast
GHRH antagonist when combined ...... ibition of human colon cancer.
@en
type
label
GHRH antagonist when combined ...... ibition of human colon cancer.
@ast
GHRH antagonist when combined ...... ibition of human colon cancer.
@en
prefLabel
GHRH antagonist when combined ...... ibition of human colon cancer.
@ast
GHRH antagonist when combined ...... ibition of human colon cancer.
@en
P2093
P2860
P356
P1433
P1476
GHRH antagonist when combined ...... ibition of human colon cancer.
@en
P2093
Andreas Stadlmayr
Awtar Krishan
Christian Datz
Ferenc G Rick
Florian Hohla
Luca Szalontay
Norman L Block
Stefan Buchholz
Stephan Seitz
P2860
P304
P356
10.4161/CC.22498
P577
2012-10-24T00:00:00Z